BFH772
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BFH772, covering 2011-03-28 to 2021-02-21. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability and Efficacy of BFH772 in Rosacea Patients [Phase 2]